LGC | GenomeWeb

LGC

The partners will evaluate several quality control assays for genome editing research, eventually creating a protocol for analyzing mutations in genomic DNA.

The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US. 

LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.

The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.

KKR Agrees to Buy LGC

The investment firm says it will acquire LGC for an undisclosed amount.

LGC will offer TraitGenetics' SNP genotyping services using Illumina and Affymetrix array technologies to its global customers.

The three-year deal includes more than 100,000 pre-designed assays for public domain human SNPs.

Registered users of the IBP will have access to a range of genotyping services through LGS.

The acquisition will enable LGC to deliver product and laboratory service offerings for core qPCR and end-point PCR applications, as well as NGS. 

LGC will distribute Holliston, Mass.-based AutoGen's FlexStar, Arrow, and QuickGene platforms in Europe, the Middle East, and Africa. 

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.